Watanabe, S., Ajisaka, R., Masuoka, T., Yamanouchi, T., Saitou, T., Toyama, M., Takeyasu, N., Sakamoto, K., and Sugishita, Y
A dose-dependent response has been observed with half (125 mg), normal (250 mg), and double (500 mg) doses, with higher doses producing greater blood sugar blunting effects
Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system [published online April 29, 2025]
Modulatory effect of L-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamicpituitaryadrenal axis
Zimmermann, C., Winnefeld, K., Streck, S., Roskos, M., & Haberl, R